Skip to content

Sepsis research based on integrated transcriptomic-metabolomic multi-omics

Sepsis research based on integrated transcriptomic-metabolomic multi-omics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106871
Enrollment
Unknown
Registered
2025-07-31
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

control group:N/A

Sponsors

Nanjing First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years; 2. Meet diagnostic criteria: Patients diagnosed with sepsis according to the Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021 (jointly issued by the European Society of Intensive Care Medicine, ESICM, and the American Society of Critical Care Medicine, SCCM) and fulfilling the Sepsis-3.0 diagnostic criteria; 3. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnancy; 2. History of neuropsychiatric disorders or current diagnosis of epilepsy, psychosis, or depression; 3. Post-cardiopulmonary cerebral resuscitation (post-CPCR); 4. HIV infection, central nervous system (CNS) infections, cerebrovascular accidents, or intracranial organic lesions; 5. Mini-Mental State Examination (MMSE) score < 24; 6. Diagnosis of Parkinson’s disease, frontotemporal dementia, Huntington’s disease, demyelinating diseases, post-traumatic dementia, or CNS infections; 7. MRI contraindications (e.g., magnetic/mechanical implants, metallic implants, cochlear implants, etc.); 8. Severe visual/hearing impairment, severe aphasia, or limb dysfunction that may interfere with assessments; 9. Prior organic brain lesions (e.g., cerebral infarction, hemorrhage) confirmed by imaging (head CT and/or MRI); 10. History of alcohol addiction or substance abuse; 11. Impaired consciousness due to other factors; 12. Missing data or loss to follow-up; 13. Autoimmune diseases; 14. Use of medications that may interfere with cognitive function evaluation; 15. Death within <3 days of observation.

Design outcomes

Primary

MeasureTime frame
RNA-seq;Metabolomics sequencing;glymphatic system;

Secondary

MeasureTime frame
peripheral blood biochemical indicators;blood routine examination;

Countries

China

Contacts

Public ContactYuan Zhang

Nanjing First Hospital

tracy_kelvin@njmu.edu.cn+86 139 5177 2008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026